Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O2 therapy

By afschroeder • April 7, 2026

Adami A, Vitacca M, Casaburi R, Salvi B, Simonelli C, Rossiter HB, Paneroni M. Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O₂ therapy. Eur J Appl Physiol. 2026 Apr 6. doi: 10.1007/s00421-026-06227-4. Epub ahead of print. PMID: 41940949.

Tags: Chronic hypoxemia, Harbor UCLA, long-term oxygen therapy, Lung diffusing capacity for carbon monoxide, Near-infrared spectroscopy, Publications, Pulmonary, Critical Care & Sleep Medicine, Skeletal muscle, smokers

MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?

Senni M, Butler J, Cyr D, Anstrom KJ, Barash I, Bonaca MP, Budoff M, Cho MC, Crespo-Leiro MG, Corda S, Ezekowitz J, Lam CSP, Lewis[...]

Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee Arthroplasty: A Propensity-Matched Cohort Study

Wiener JM, Hamad CD, Chun RF, Mehany JD, Yeaman MR, Sheppard WL, Bernthal NM. Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee[...]

Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024

Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles[...]